Stockholders’ Equity (Tables)

6 Months Ended

Jun. 30, 2026

A summary of the Company’s stock option activity for the six months ended June 30, 2026 and related information is as follows (in thousands, except per share data):


	Number of Options	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value
Outstanding at December 31, 2025	12,914	$	2.73	4.4	$	1,461
Options granted	—	$	—
Options exercised	(969)	$	1.64
Options forfeited or expired	(1,722)	$	3.57
Outstanding at June 30, 2026	10,223	$	2.69	4.3	$	1,389
Exercisable at June 30, 2026	10,223	$	2.69	4.3	$	1,389
Vested or expected to vest at June 30, 2026	10,223	$	2.69	4.3	$	1,389

Schedule of Restricted Stock Unit Activity

A summary of the Company’s RSU activity for the six months ended June 30, 2026 and related information is as follows (in thousands, except per share data):


	Number of Shares	Weighted Average Grant Date Fair Value
Unvested at December 31, 2025	47,101	$	1.95
RSUs granted	37,510	$	1.75
RSUs vested	(13,012)	$	2.05
RSUs forfeited	(3,927)	$	1.74
Unvested at June 30, 2026	67,672	$	1.83

Schedule of Assumptions Used to Calculate Fair Value

The following assumptions were used to calculate the fair value of market-based PSUs made during the following periods:


	Six Months Ended June 30,
	2026	2025
Expected volatility	63.9% - 65.4%	66.5%
Expected term (in years)	3.8 - 3.9	4.9
Risk-free interest rate	3.6% - 3.9%	4.1%
Expected dividend yield	—	—

Schedule of Stock-based Compensation Expense

The Company recorded stock-based compensation expense in the condensed consolidated statements of operations as follows (in thousands):


	Three Months Ended June 30,				Six Months Ended June 30,
	2026		2025		2026		2025
Cost of revenue	$	555	$	739	$	1,177	$	1,484
Research and development	8,039		9,676		16,402		18,864
Sales and marketing	2,028		2,223		3,963		4,695
General and administrative	4,251		4,469		8,093		9,155
Total	$	14,873	$	17,107	$	29,635	$	34,198